Can a Pill Slow Down Alzheimer’s?
The first pill to slow down Alzheimer’s disease is being analysed for potential use on the NHS, with regulators set to make a decision in April. The daily medication, called hydromethylthionine mesylate (HMTM), was developed by British firm TauRX in Aberdeen.
If approved by both the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute of Health and Care Excellence (Nice), it would mark the most significant advancement in NHS dementia treatment in decades. The development follows the rejection of two other Alzheimer’s drugs earlier this year on cost grounds.
HMTM works by preventing the build-up of tau protein clumps in the brain, which can damage neurons and lead to cognitive decline.
Excerpted from GB News
